Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $24.7 million.

  • Bio-Techne's Depreciation & Amortization (CF) fell 876.9% to $24.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $103.7 million, marking a year-over-year decrease of 620.13%. This contributed to the annual value of $109.9 million for FY2025, which is 161.85% down from last year.
  • Per Bio-Techne's latest filing, its Depreciation & Amortization (CF) stood at $24.7 million for Q4 2025, which was down 876.9% from $24.3 million recorded in Q3 2025.
  • Bio-Techne's 5-year Depreciation & Amortization (CF) high stood at $28.5 million for Q3 2023, and its period low was $21.1 million during Q1 2021.
  • For the 5-year period, Bio-Techne's Depreciation & Amortization (CF) averaged around $26.2 million, with its median value being $26.8 million (2022).
  • As far as peak fluctuations go, Bio-Techne's Depreciation & Amortization (CF) soared by 2020.57% in 2022, and later tumbled by 1349.47% in 2025.
  • Quarter analysis of 5 years shows Bio-Techne's Depreciation & Amortization (CF) stood at $25.1 million in 2021, then rose by 6.38% to $26.7 million in 2022, then rose by 4.12% to $27.8 million in 2023, then decreased by 2.59% to $27.1 million in 2024, then fell by 8.77% to $24.7 million in 2025.
  • Its last three reported values are $24.7 million in Q4 2025, $24.3 million for Q3 2025, and $27.1 million during Q2 2025.